Cleared Traditional

K072045 - ONCONTROL BONE MARROW BIOPSY SYSTEM

K072045 is an FDA 510(k) clearance for ONCONTROL BONE MARROW BIOPSY SYSTEM, manufactured by Vidacare Corporation. The device is a Class 2 Gastroenterology & Urology device with product code KNW cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K072045 · Vidacare Corporation · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2007
Decision
89d
Days
Class 2
Risk

K072045 is an FDA 510(k) clearance for the ONCONTROL BONE MARROW BIOPSY SYSTEM. Classified as Instrument, Biopsy (product code KNW), Class II - Special Controls.

Submitted by Vidacare Corporation (Irvine, US). The FDA issued a Cleared decision on October 22, 2007 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vidacare Corporation devices

FDA 510(k) Submission Details - K072045

510(k) Number K072045 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2007
Decision Date October 22, 2007
Days to Decision 89 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 131d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KNW Device Classification - Class 2, Special Controls

Product Code KNW Instrument, Biopsy
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KNW Instrument, Biopsy

All 306
Devices cleared under the same product code (KNW) and FDA review panel - the closest regulatory comparables to K072045.
INTACT BREAST LESION EXCISION SYSTEM WITH INTACT EXCISION XL
K081057 · Intact Medical Corporation · Jun 2008
CORAMATE/SPIROTOME SYSTEM
K080095 · Medinvents · Apr 2008
SANARUS INCORE ROTATIONAL CORE BIOPSY DEVICE, MODELS CB3010, CB3012
K080171 · Sanarus Medical, Inc. · Mar 2008
LIGHT SABRE SPINAL ACCESS DEVICE
K071814 · Minrad, Inc. · Oct 2007
RUBICOR MAGIC BREAST BIOPSY DEVICE, MODEL 31537
K071048 · Rubicor Medical, Inc. · May 2007
DELTACUT (APPARATUS AND CANNULA)
K063233 · PAJUNK GmbH Medizintechnologie · Apr 2007